| Literature DB >> 15887956 |
Simon E Ward1, Frank P Harrington, Laurie J Gordon, Susanna C Hopley, Claire M Scott, Jeannette M Watson.
Abstract
A series of 5-(piperidinylethyloxy)quinoline 5-hydroxytryptamine(1D) (5-HT(1D)) receptor antagonists have been discovered from elaboration of the series of dual 5-hydroxytryptamine(1)-selective serotonin reuptake inhibitors (5HT(1)-SSRIs) reported previously. This is the first report of highly potent, selective antagonists for the 5-HT(1D) receptor, which represents an extremely useful set of pharmacological tools for further understanding the roles of the 5-HT(1) receptor subtypes.Entities:
Mesh：
Substances：
Year: 2005 PMID： 15887956 DOI： 10.1021/jm049039v
Source DB: PubMed Journal: J Med Chem ISSN： 0022-2623 Impact factor: 7.446